HUSSAIN IQBAL J (General Counsel) sold 5.4% of their position (6K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $165.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/18/2025ACC: 0001470831-25-000344
Officer· General Counsel
Since May 2021
-6K
Net shares
Net seller
$165.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+6K
Price / share
$5.84
Trade value
$35.04K
% of position
5.7%
11/17/2025
105.39K→111.39K
Ordinary Shares
Direct
Shares
−6K
Price / share
$27.64
Trade value
$165.84K
% of position
5.4%
11/17/2025
111.39K→105.39K
Total
Net shares
+0.00
Net value
-$130.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/17/2025 | M · Option Exercise | +6K | $5.84 | $35.04K | 5.7% | 105.39K | 111.39K |
| Ordinary Shares Direct | 11/17/2025 | S · Sale | −6K | $27.64 | $165.84K | 5.4% | 111.39K | 105.39K |
| Total | +0.00 | -$130.80K | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
6K shares
Shares
−6K
Strike price
5.84
Held after
221.56K
Exercisable
—
11/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares6K shares | 11/17/2025 | M · Option Exercise | −6K | 5.84 | — | 221.56K |